Crossmark

Development and validation of an Immune-related Gene-based model for predicting prognosis and immunotherapy outcomes in hepatocellular carcinoma patients

Crossref DOI link: https://doi.org/10.1038/s41598-025-90183-0

Published Online: 2025-02-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

You, Penghui

Liu, Xiaoling

Wang, Min

Zhan, Yanbing

Chen, Lihong

Chen, Yi
Funding

Funding for this research was provided by:

Fujian Provincial Health Commission Medical Innovation Research Project (2023CXA051)

Fuzhou Science and Technology Bureau (2022-S-011)
License Information

Text and Data Mining valid from 2025-02-24

Version of Record valid from 2025-02-24
More Information

Article History

Received: 20 November 2024

Accepted: 11 February 2025

First Online: 24 February 2025

Declarations

:

: The authors have no conflicts of interest to disclose.

Document is current

Any future updates will be listed below